News

Find News

Filter articles

Showing 2701 to 2710 of 2715 results

India rejects Bayer plea over compulsory licence

04-03-2013

India’s patent authorities have dealt a blow to German pharma company Bayer by refusing to overturn an order forcing the company to license one of its patented drugs.

ViiV Healthcare joins patent pool for cheaper AIDS drugs

28-02-2013

ViiV Healthcare, a public health joint venture between GlaxoSmithKline, Shionogi and Pfizer, has signed up to the Medicines Patent Pool (MPP) to provide greater access to affordable AIDS treatments in developing countries.

UK patent change paves way for pharma innovation

26-02-2013Legal developments

The UK government announced a change to the Patent Act on Tuesday that will allow parties to run drug trials without infringing other parties’ patents.

FDA approves generic heroin substitutes

US26-02-2013

The US Food and Drug Administration has approved two generic versions of Reckitt Benckiser’s heroin replacement tablet Suboxone – despite Reckitt’s claims that the product is unsafe.

BRICK nations catching up on patents, as Brazil looks to life sciences

Brazil, China, India, Russia, South Korea25-02-2013

In a report published by Thomson Reuters on February 20, the BRICK nations were shown to be filing almost as many patents as the G7 nations in 2011.

UK appeals court upholds Genentech patent

UK25-02-2013Legal developments

England’s Court of Appeal has affirmed a 2012 High Court ruling that pharmaceutical company Genentech’s patent covering human vascular endothelial growth factor antagonists is valid and has been infringed by Regeneron and Bayer Pharmaceutical’s drug Eylea.

US appeals court upholds AstraZeneca’s Seroquel XR patent

US19-02-2013Legal developments

The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.

Teva faces $2 billion damages for selling generic Protonix

Israel18-02-2013

Israeli company Teva Pharmaceuticals could be forced to pay more than $2 billion in damages for selling a generic version of Nycomed and Pfizer’s heartburn reliever Protonix before the drug’s patent exclusivity expired in the US.

Australian court backs Myriad in human gene patent dispute

Australia18-02-2013

A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented.

Bristol-Myers Squibb loses Baraclude patent fight with Teva

US14-02-2013

A US judge has declared pharmaceutical company Bristol-Myers Squibb’s patent covering its hepatitis B treatment Baraclude obvious and invalid.

Showing 2701 to 2710 of 2715 results

LSIPR